Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, Graz, Austria.
Institute of Molecular Biosciences, Biochemistry, University of Graz, Graz, Austria.
Nat Commun. 2024 Mar 21;15(1):2516. doi: 10.1038/s41467-024-46937-x.
ATGL is a key enzyme in intracellular lipolysis and plays an important role in metabolic and cardiovascular diseases. ATGL is tightly regulated by a known set of protein-protein interaction partners with activating or inhibiting functions in the control of lipolysis. Here, we use deep mutational protein interaction perturbation scanning and generate comprehensive profiles of single amino acid variants that affect the interactions of ATGL with its regulatory partners: CGI-58, G0S2, PLIN1, PLIN5 and CIDEC. Twenty-three ATGL amino acid variants yield a specific interaction perturbation pattern when validated in co-immunoprecipitation experiments in mammalian cells. We identify and characterize eleven highly selective ATGL switch mutations which affect the interaction of one of the five partners without affecting the others. Switch mutations thus provide distinct interaction determinants for ATGL's key regulatory proteins at an amino acid resolution. When we test triglyceride hydrolase activity in vitro and lipolysis in cells, the activity patterns of the ATGL switch variants trace to their protein interaction profile. In the context of structural data, the integration of variant binding and activity profiles provides insights into the regulation of lipolysis and the impact of mutations in human disease.
脂肪甘油三酯酶(ATGL)是细胞内脂肪分解的关键酶,在代谢和心血管疾病中发挥着重要作用。ATGL 受到一系列已知的蛋白-蛋白相互作用伙伴的严格调控,这些伙伴具有激活或抑制脂肪分解的功能。在这里,我们使用深度突变蛋白相互作用扰动扫描,并生成了一组综合的单氨基酸变异体图谱,这些变异体影响 ATGL 与其调节伙伴 CGI-58、G0S2、PLIN1、PLIN5 和 CIDEC 的相互作用。在哺乳动物细胞中的共免疫沉淀实验中验证了 23 种 ATGL 氨基酸变异体,它们产生了特定的相互作用扰动模式。我们鉴定并表征了十一个高度选择性的 ATGL 开关突变,这些突变影响五个伙伴之一的相互作用,而不影响其他伙伴。因此,开关突变在氨基酸分辨率上为 ATGL 的关键调节蛋白提供了独特的相互作用决定因素。当我们在体外测试甘油三酯水解酶活性和细胞内脂肪分解时,ATGL 开关变体的活性模式可追溯到其蛋白相互作用图谱。在结构数据的背景下,结合和活性图谱的整合提供了对脂肪分解调节以及人类疾病中突变影响的深入了解。